TL Ventures

TL Ventures is an investment firm based in Wayne, Pennsylvania, founded in 1988. The firm specializes in venture capital, focusing on companies within the software, information technology, and business services sectors. TL Ventures is committed to providing financial services to its clients, primarily in the United States, and aims to support innovative companies that demonstrate potential for growth and success in their respective markets.

Mark DeNino

Managing Director

Guy Hoffman

Partner

Robert E. Keith, Jr.

Managing Director, Co-Founder and CEO

116 past transactions

Donuts

Series C in 2015
Donuts Inc is the registry of next generation domain names. With nearly 200 top-level domains, and millions of registrants, Donuts offers a wide variety of clear and meaningful names that represent your identity online in the best possible way. Whether looking for business identifiers (.ltd), navigation (.support), vertical market specifics (.builders) or broad-based generics (.world), their portfolio offers unequaled precision and differentiation. Using their industry-first DPML product, they also work with a large majority of the top global brands to protect their trademarks online. With office locations in Seattle, Washington DC, Los Angeles, London and Hong Kong, they sell their products through the world's leading registrars and resellers, including Go Daddy, Alibaba and 1and1.

iSpot.tv

Series A in 2013
iSpot.tv, Inc. is a company specializing in real-time analytics for television advertising, providing insights into the effectiveness of ad campaigns across various broadcast and cable networks, as well as smart TVs. Founded in 2012 and headquartered in Bellevue, Washington, iSpot.tv offers a platform that allows advertisers to track ad creatives, airings, spending, and viewer impressions with a level of precision akin to digital metrics. The platform measures consumer engagement, assesses the impact of TV and streaming ads on sales, and provides actionable insights that enable advertisers to refine their media strategies and enhance creative effectiveness. iSpot.tv serves a diverse clientele, including television brands, networks, and studios, helping them to gauge the business impact of their advertising efforts in real-time.

Moonshoot

Venture Round in 2012
Moonshoot's mission is to spark English language learning in children everywhere. It has launched its service in Japan in April 2010. Moonshoot makes learning English fun and exciting for children by using online games. Moonshoot's first release starts with a concrete goal of helping child build a vocabulary of 600 words, 200 phrases, that will enable them to read up to 50 classic children's books.

Pivotal Systems

Venture Round in 2012
Pivotal Systems Corporation specializes in designing, developing, and manufacturing gas flow controllers for the semiconductor industry, primarily in Asia and North America. Founded in 2003 and based in Fremont, California, the company offers a technology platform that includes innovative hardware and software solutions. Their products, such as gas flow controllers and monitors, utilize advanced machine learning to enhance monitoring and control of critical parameters in wafer processing, thereby improving productivity and efficiency in semiconductor fabrication. Pivotal Systems serves a diverse clientele, including integrated device manufacturers, foundries, and original equipment manufacturers, with a significant portion of its revenue generated from the Asian market.

Global Education Learning

Venture Round in 2012
Global Education Learning (GEL) aims to deliver high-quality educational products and services to young children in China, focusing on subjects such as English, Chinese, math, and science while also fostering emotional intelligence, creativity, and strong values. Its subsidiary, Yaolan, is a well-respected platform catering to parents of children aged 0-6, boasting a significant brand presence across the nation. GEL's strategic advantage lies in its comprehensive distribution network that spans first, second, and third-tier cities, which helps differentiate it in the competitive landscape. The initial phase of GEL’s strategy involves leveraging Yaolan as an online foundation, supplemented by offline distribution through learning centers and physical stores. In subsequent phases, GEL plans to invest in high-quality content and technology both domestically and internationally. With a management team experienced in the for-profit education sector, GEL aims to become a key partner for companies seeking to enter the Chinese education market, supported by a robust distribution engine and proprietary insights into emerging educational opportunities.

Noble Biomaterials

Series B in 2012
Noble Biomaterials, Inc. specializes in antimicrobial and conductivity solutions for soft surface applications, offering a range of products including fibers, fabrics, and custom components. The company's notable technologies include X-STATIC, a silver-based antimicrobial solution that protects against bacteria, fungi, and odor, and XT2, which provides long-lasting antimicrobial protection. Additionally, Noble Biomaterials offers X-STATIC SOFT SURFACE PROTECTION for medical devices and CIRCUITEX, a solution for biometric monitoring and conductive protection. The company serves a diverse array of markets including apparel, healthcare, electronics, and military, both domestically and internationally. Founded in 1997 and headquartered in Scranton, Pennsylvania, Noble Biomaterials has expanded its reach with offices in Europe, Asia, and South America, and maintains strategic partnerships with companies such as ANTA Sports Products Limited and Pure Air Filtration, LLC.

Donuts

Series A in 2012
Donuts Inc is the registry of next generation domain names. With nearly 200 top-level domains, and millions of registrants, Donuts offers a wide variety of clear and meaningful names that represent your identity online in the best possible way. Whether looking for business identifiers (.ltd), navigation (.support), vertical market specifics (.builders) or broad-based generics (.world), their portfolio offers unequaled precision and differentiation. Using their industry-first DPML product, they also work with a large majority of the top global brands to protect their trademarks online. With office locations in Seattle, Washington DC, Los Angeles, London and Hong Kong, they sell their products through the world's leading registrars and resellers, including Go Daddy, Alibaba and 1and1.

BostInno

Seed Round in 2011
BostInno is a Boston-based online news portal that delivers news related to business, technology, education, and sports. It is operated by [Streetwise Media](http://www.crunchbase.com/organization/streetwise-media), a digital media and events company. Its editorial staff consists of fast, edgy, and opinionated members, and it is an open community publishing platform. BostInno was founded in 2001 and is based in Boston, M.A.

SkyCross

Series E in 2011
Skycross is a global company specializing in wireless antenna solutions and advanced radiofrequency technology systems. The company caters to a diverse range of market segments, including handsets, data cards, USB dongles, laptops, access points, and mobile personal entertainment devices. Skycross is recognized for its innovative VersiTune integrated modules and antennas, which leverage patented technologies such as beam-forming, pattern diversity, and closed-loop tuning. These advancements enhance the performance of mobile and connectivity applications, facilitating improved communication and supporting the development of a more connected world.

AirWalk Communications

Series B in 2011
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company offers a range of products, including the EdgePoint Femtocell, designed for home and small office use, and the EdgePoint PRO, which caters to office and campus environments. Their PilotStation facilitates the transmission of essential channels in CDMA networks, while the Base Station Manager serves as an open standards-based, scalable solution for managing their software systems. AirWalk's innovative approach integrates controller functionality directly with base station transceivers in a compact device, leading to reduced equipment complexity and latency. This design enhances reliability, simplifies installation, lowers costs, and minimizes the system footprint for service providers.

Celator Pharmaceuticals

Series D in 2010
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

Velsys

Venture Round in 2010
Velsys Limited is a global financial technology services provider specializing in foreign exchange (FX) trading solutions for banks, brokers, and financial institutions. Founded in 1996 and headquartered in Adelaide, Australia, with an office in London, Velsys offers a suite of FX software applications, including its flagship V-Banking platform. This web-based e-trading software facilitates the development, management, and electronic distribution of financial products, focusing on pricing, liquidity, and integration. Velsys caters to a diverse clientele, supporting both large and small financial institutions worldwide, and offers flexible deployment options, including a fully hosted service. The company's solutions are particularly designed to meet the needs of mid- and smaller-sized regional banks.

Moonshoot

Venture Round in 2010
Moonshoot's mission is to spark English language learning in children everywhere. It has launched its service in Japan in April 2010. Moonshoot makes learning English fun and exciting for children by using online games. Moonshoot's first release starts with a concrete goal of helping child build a vocabulary of 600 words, 200 phrases, that will enable them to read up to 50 classic children's books.

Translarity

Series B in 2009
Translarity is a pioneering company in the semiconductor wafer test sector, specializing in advanced probe card solutions. Based in Silicon Valley, the company has introduced a disruptive full-wafer testing approach that emphasizes low cost, high performance, and reduced cycle times. In 2017, Translarity expanded its capabilities through the acquisition of BucklingBeam, enhancing its product offerings with a comprehensive range of probe card solutions, including full probe cards and vertical probe head technologies. The company's innovative Space Translator™ technology positions it well to meet the fast-evolving demands of probe technologies. With a strong management team and significant backing from financial investors, Translarity has built a robust innovation pipeline and intellectual property portfolio, boasting over 45 issued patents and more than 50 additional patents filed. The company aims to address critical challenges in semiconductor testing, facilitating efficient wafer-level and advanced package tests in the industry.

Finite Carbon

Series A in 2009
Finite Carbon Corporation specializes in forest carbon development and commercialization services across the United States. The company provides forest landowners with a comprehensive solution to access carbon markets, facilitating the measurement, registration, monitoring, and monetization of carbon credits. It offers resources and capital for implementing forest carbon inventories, pre-assessment carbon modeling, protocol selection, project design, verification management, and marketing of carbon credits. By managing all phases of project development in-house, Finite Carbon assumes risks and expenses associated with project issuance, ensuring that landowners' carbon projects align with their forest ownership goals and timber operations. Established in 2009 and based in Wayne, Pennsylvania, the company operates as a subsidiary of BP p.l.c. as of December 2020.

Celator Pharmaceuticals

Series C in 2008
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

ScaleMP

Series D in 2008
ScaleMP, Inc. specializes in virtualization solutions tailored for high-end computing. The company's flagship product, the vSMP Foundation, allows users to transform multiple standard x86 servers into a single virtual high-end system. This innovative approach enables organizations to optimize resource utilization through shared and distributed-memory workloads. ScaleMP also offers various modes, including Memory Expansion for applications requiring significant memory capacity and System Expansion for compute-intensive tasks. Its solutions cater to diverse sectors such as life sciences, manufacturing, higher education, energy discovery, and financial services, enhancing performance while reducing costs. Founded in 2003 and based in Fort Lee, New Jersey, ScaleMP delivers its products through channel partners and regional sellers both domestically and internationally.

Kleer

Series B in 2008
Kleer combines an advanced, cloud-based platform with dedicated and personalized support to ensure your practice has everything you need to easily and quickly design, implement, and professionally manage a successful membership plan. Kleer has implemented membership plans for 7,000+ dentists and has a team dedicated to your success.

AirWalk Communications

Series B in 2008
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company offers a range of products, including the EdgePoint Femtocell, designed for home and small office use, and the EdgePoint PRO, which caters to office and campus environments. Their PilotStation facilitates the transmission of essential channels in CDMA networks, while the Base Station Manager serves as an open standards-based, scalable solution for managing their software systems. AirWalk's innovative approach integrates controller functionality directly with base station transceivers in a compact device, leading to reduced equipment complexity and latency. This design enhances reliability, simplifies installation, lowers costs, and minimizes the system footprint for service providers.

Sopherion Therapeutics

Venture Round in 2008
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.

NorthStar Systems International

Venture Round in 2007
NorthStar Systems International, Inc. provides wealth management software solutions to financial services institutions primarily in the United States. Its solutions include NorthStar Client Acquisition Solution that allows asset managers and wealth management firms to provide their advisors the client profiling and communication tools; NorthStar Client Reporting Solution, which enables wealth managers to offer reports and reviews for clients; NorthStar Compliance Solution that offers compliance systems' functionalities; and NorthStar Product Catalog Solution, which allows wealth managers to build customized portfolios. The company also offers client hierarchy, enterprise product hub, planning and portfolio construction, data, and platform services; and professional and technical support services. Its solutions allow users to automate and streamline their wealth management workflows. The company serves financial advisors, wealth managers, banks, trusts, broker-dealers, multi-family offices, and service providers. It delivers its solutions on-premise or on-demand. The company was founded in 2001 and is based in San Francisco, California.

Optichron

Venture Round in 2007
Optichron, Inc. specializes in nonlinear signal processing technology, designing and manufacturing integrated circuits that enhance cost and performance in communications applications. Founded in January 2003, the company addresses the challenge of nonlinear distortion, a significant barrier in signal processing across various industries. This distortion hinders optimal performance in areas such as communications and data conversion. Optichron's team has developed a proprietary mathematical approach that underpins a robust integrated circuit architecture, forming the basis of its linearization products. By effectively mitigating nonlinear distortion, the company's technology improves overall system design parameters, resulting in reduced component counts and improved efficiency, ultimately lowering costs and power consumption. Optichron's products find applications in diverse fields, including wireless communications, software-defined radio, medical imaging, satellite communications, radar, infrared imaging, and test and measurement instrumentation, supported by a digital pre-distortion development tool suite for design migration across multiple protocols.

Celator Pharmaceuticals

Series C in 2007
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

QuatRx Pharmaceuticals

Series E in 2007
QuatRx Pharmaceuticals is a biopharmaceutical company focused on the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Founded in 2000 and headquartered in Ann Arbor, Michigan, the company offers products such as Osphena, which addresses vaginal atrophy associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related conditions in men. Through its innovative approach, the company aims to improve patient outcomes in these therapeutic areas.

NetEffect Sytems

Series C in 2007
NetEffect has offered dependable cybersecurity and IT services to companies in Las Vegas.

Ciclon Semiconductor Device

Series B in 2007
Ciclon Semiconductor Device Corporation specializes in designing, developing, and selling high-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor solutions tailored for advanced information technology applications. Founded in 2004 and headquartered in Bethlehem, Pennsylvania, the company provides a range of RF and power semiconductor products that include ceramic and plastic packaged RoHS-compliant discrete options. These products cater to various high-performance applications, such as communications, military, avionics, broadcast, and WiMax. As of 2009, Ciclon operates as a subsidiary of Texas Instruments Inc.

Atrenta

Venture Round in 2006
Atrenta is a provider of innovative solutions for the semiconductor and consumer electronics industries, specializing in design efficiency through its SpyGlass Predictive Analysis software platform. This platform offers early design insights into the performance, power, and area requirements of complex system on chips (SoCs), which are essential for modern consumer electronics. By enabling design engineers to identify structural, coding, and consistency issues in register transfer language (RTL), Atrenta's technology allows for enhanced testability during RTL creation. The company's patented solutions are utilized by over two hundred companies and thousands of design engineers globally, helping to mitigate risks and reduce costs before the deployment of traditional electronic design automation (EDA) tools. SpyGlass serves as an interactive guidance system, optimizing the implementation process for complex SoCs and ensuring greater efficiency and confidence in design outcomes.

AirWalk Communications

Series B in 2006
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company offers a range of products, including the EdgePoint Femtocell, designed for home and small office use, and the EdgePoint PRO, which caters to office and campus environments. Their PilotStation facilitates the transmission of essential channels in CDMA networks, while the Base Station Manager serves as an open standards-based, scalable solution for managing their software systems. AirWalk's innovative approach integrates controller functionality directly with base station transceivers in a compact device, leading to reduced equipment complexity and latency. This design enhances reliability, simplifies installation, lowers costs, and minimizes the system footprint for service providers.

VeriWave

Series C in 2006
VeriWave specializes in providing testing systems for WiFi and Ethernet networks, focusing on ensuring optimal performance for mobile networks, devices, and applications. The company supports manufacturers, service providers, and end-users throughout the entire lifecycle of mobile technology, from development to deployment and beyond. VeriWave's offerings include tools designed to measure, analyze, and enhance key aspects of mobile performance, such as speed, quality, interoperability, and compliance. Additionally, the company supplies WiFi access points, wireless LAN controllers, residential routers, gateways, WiFi-enabled client devices, Ethernet switches, and branch office routers, catering to the needs of equipment manufacturers and enhancing the overall efficiency of mobile networks.

JAM Technologies

Series B in 2006
JAM Technologies operates as a mixed signal semiconductor company. It designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. JamTech offers True Fidelity sub-ranging pulse width modulation digital amplifiers. It sells its ICs through direct sales force and distributors. The company was founded in 1999 and is headquartered in Austin, Texas, with an additional office in Singapore.

ClariFI

Venture Round in 2006
ClariFI, Inc. provides software and services focusing on quantitative investment management and research. It offers ModelStation, a solution with data management, factor backtesting, model construction, strategy simulation, portfolio optimization, risk and performance attribution, production scheduling, and enterprise adoption modules. The company's services include data integration and management, workflow creation, statistical/computational algorithms, risk model development, forecast model development, and strategy script development. It also provides integration services to in-house data warehouses or custom feeds. The company was founded in 1999 and is headquartered in New York, New York with additional offices in Boston, Massachusetts; El Segundo, California; and London, United Kingdom. As of May 15, 2007, ClariFI, Inc. operates as a subsidiary of Capital IQ, Inc.

SkyCross

Series C in 2006
Skycross is a global company specializing in wireless antenna solutions and advanced radiofrequency technology systems. The company caters to a diverse range of market segments, including handsets, data cards, USB dongles, laptops, access points, and mobile personal entertainment devices. Skycross is recognized for its innovative VersiTune integrated modules and antennas, which leverage patented technologies such as beam-forming, pattern diversity, and closed-loop tuning. These advancements enhance the performance of mobile and connectivity applications, facilitating improved communication and supporting the development of a more connected world.

Sonics

Series D in 2005
Sonics is a leading provider of network-on-chip (NoC) technology, specializing in intelligent on-chip communications solutions for various applications, including home entertainment, wireless networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company offers a comprehensive portfolio of silicon-proven intellectual property (IP) that addresses the memory bottlenecks and data flow challenges associated with complex, high-speed system-on-chip (SoC) designs. By enabling heterogeneous, multi-core SoC architectures, Sonics integrates essential subsystems, such as security, power, and memory, to deliver high performance and low power consumption. Its innovative technology has facilitated the shipment of over 750 million units globally, positioning Sonics as a key player in the embedded market.

Translarity

Series A in 2005
Translarity is a pioneering company in the semiconductor wafer test sector, specializing in advanced probe card solutions. Based in Silicon Valley, the company has introduced a disruptive full-wafer testing approach that emphasizes low cost, high performance, and reduced cycle times. In 2017, Translarity expanded its capabilities through the acquisition of BucklingBeam, enhancing its product offerings with a comprehensive range of probe card solutions, including full probe cards and vertical probe head technologies. The company's innovative Space Translator™ technology positions it well to meet the fast-evolving demands of probe technologies. With a strong management team and significant backing from financial investors, Translarity has built a robust innovation pipeline and intellectual property portfolio, boasting over 45 issued patents and more than 50 additional patents filed. The company aims to address critical challenges in semiconductor testing, facilitating efficient wafer-level and advanced package tests in the industry.

QuatRx Pharmaceuticals

Series D in 2005
QuatRx Pharmaceuticals is a biopharmaceutical company focused on the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Founded in 2000 and headquartered in Ann Arbor, Michigan, the company offers products such as Osphena, which addresses vaginal atrophy associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related conditions in men. Through its innovative approach, the company aims to improve patient outcomes in these therapeutic areas.

Ciclon Semiconductor Device

Series A in 2005
Ciclon Semiconductor Device Corporation specializes in designing, developing, and selling high-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor solutions tailored for advanced information technology applications. Founded in 2004 and headquartered in Bethlehem, Pennsylvania, the company provides a range of RF and power semiconductor products that include ceramic and plastic packaged RoHS-compliant discrete options. These products cater to various high-performance applications, such as communications, military, avionics, broadcast, and WiMax. As of 2009, Ciclon operates as a subsidiary of Texas Instruments Inc.

Zalicus

Series E in 2005
Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on developing drug candidates for the treatment of pain and inflammation. The company leverages its expertise in ion-channel modulation to discover innovative therapeutics, both for its internal product pipelines and in collaboration with other entities. Zalicus invests significantly in research and development, including preclinical and clinical trials, while also pursuing intellectual property protection for its technologies and product candidates. One of its notable achievements includes the FDA approval of Exalgo, an extended-release formulation of hydromorphone HCl, which is indicated for managing moderate to severe pain in opioid-tolerant patients. The company was formed following the merger with Neuromed Pharmaceuticals in December 2009.

Intellon Corporation

Series B in 2005
Intellon Corporation, a fabless semiconductor company, engages in the design, develop, manufacture, and marketing of integrated circuits (ICs) for powerline communications or high-speed communications over existing electrical wiring in the United States and internationally. They provides HomePlug-based ICs for home networking, networked entertainment, broadband over powerline access, ethernet-over-coax, smart grid management, and other commercial applications. The HomePlug-based ICs provide connectivity between broadband modems or routers and personal computers, set-top boxes, gaming consoles, and other electronic products within a home; and monitors electrical distribution system, as well as helps in distributing Internet, video-on-demand, and other services.

Apogee Photonics

Venture Round in 2005
Apogee Photonics, Inc. is a company specializing in the design, development, and production of advanced optoelectronic solutions for optical transmission systems. Founded in 2000 and headquartered in Allentown, Pennsylvania, with an additional office in New Jersey, Apogee Photonics offers integrated indium phosphide products that enhance the distance-extinction-power product compared to other optical semiconductor technologies. Their product range includes cooled, semi-cooled, and uncooled solutions for 10Gb/s and 40Gb/s transmission, catering to tier 1 system original equipment manufacturers (OEMs) and module vendors. Key offerings encompass thermistor-based temperature monitoring, modulator-based power monitoring products, electroabsorption-modulated lasers, and laser integrated modulators. The company extends its market presence through sales locations in the United States, Canada, Europe, Israel, and Asia.

VeriWave

Series B in 2005
VeriWave specializes in providing testing systems for WiFi and Ethernet networks, focusing on ensuring optimal performance for mobile networks, devices, and applications. The company supports manufacturers, service providers, and end-users throughout the entire lifecycle of mobile technology, from development to deployment and beyond. VeriWave's offerings include tools designed to measure, analyze, and enhance key aspects of mobile performance, such as speed, quality, interoperability, and compliance. Additionally, the company supplies WiFi access points, wireless LAN controllers, residential routers, gateways, WiFi-enabled client devices, Ethernet switches, and branch office routers, catering to the needs of equipment manufacturers and enhancing the overall efficiency of mobile networks.

Celator Pharmaceuticals

Series B in 2005
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for cancer treatment. Utilizing its proprietary CombiPlex technology platform, the company specializes in creating optimized drug combinations that integrate traditional chemotherapies with molecularly targeted agents to enhance anti-cancer efficacy. Celator's product pipeline includes VYXEOS, a liposomal formulation of irinotecan and floxuridine, currently undergoing Phase III clinical trials for acute myeloid leukemia (AML). Additionally, CPX-351, another liposomal formulation of cytarabine and daunorubicin, is also in Phase III studies for AML. CPX-1, a combination of irinotecan and floxuridine, has completed Phase II trials targeting colorectal cancer. The company also has a preclinical candidate, CPX-8, which is a nanoparticle formulation of docetaxel. Founded in 1999 and headquartered in Ewing, New Jersey, Celator Pharmaceuticals operates as a subsidiary of Jazz Pharmaceuticals Public Limited Company.

Ventaira Pharmaceuticals

Series C in 2005
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to the development of innovative inhalation products. The company employs its proprietary electrohydrodynamic aerosolization and formulation technologies to create new inhaled drugs. Among its key products are fentanyl, aimed at treating breakthrough pain, and salmeterol, used for asthma management. Ventaira Pharmaceuticals focuses on advancing its unique technologies to enhance drug delivery and improve treatment options for patients.

Optichron

Series B in 2005
Optichron, Inc. specializes in nonlinear signal processing technology, designing and manufacturing integrated circuits that enhance cost and performance in communications applications. Founded in January 2003, the company addresses the challenge of nonlinear distortion, a significant barrier in signal processing across various industries. This distortion hinders optimal performance in areas such as communications and data conversion. Optichron's team has developed a proprietary mathematical approach that underpins a robust integrated circuit architecture, forming the basis of its linearization products. By effectively mitigating nonlinear distortion, the company's technology improves overall system design parameters, resulting in reduced component counts and improved efficiency, ultimately lowering costs and power consumption. Optichron's products find applications in diverse fields, including wireless communications, software-defined radio, medical imaging, satellite communications, radar, infrared imaging, and test and measurement instrumentation, supported by a digital pre-distortion development tool suite for design migration across multiple protocols.

T-Networks

Series C in 2005
Electronic Components, Modulators available from T-Networks Inc. based in Allentown, PA.

Blaze Public Relations

Venture Round in 2005
The Blaze Company provides marketing communications services to travel, retail, entertainment, magazines, institutes, and financial services industries. The company offers press conference, media placement analysis, direct mail, event marketing, public relations, online research, and strategic corporate counsel. Its clientele includes Seagrams, Denis Austin, Cruise & Resort Magazine, Hollywood Marketing Corporation, Cafй Med, Tomy America Inc., and Glad Bags. The company is based in Venice, California. As of 05/12/2004, The Blaze Company is a subsidiary of Davies.

QuatRx Pharmaceuticals

Series D in 2004
QuatRx Pharmaceuticals is a biopharmaceutical company focused on the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Founded in 2000 and headquartered in Ann Arbor, Michigan, the company offers products such as Osphena, which addresses vaginal atrophy associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related conditions in men. Through its innovative approach, the company aims to improve patient outcomes in these therapeutic areas.

Sopherion Therapeutics

Series B in 2004
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.

AirWalk Communications

Series A in 2004
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company offers a range of products, including the EdgePoint Femtocell, designed for home and small office use, and the EdgePoint PRO, which caters to office and campus environments. Their PilotStation facilitates the transmission of essential channels in CDMA networks, while the Base Station Manager serves as an open standards-based, scalable solution for managing their software systems. AirWalk's innovative approach integrates controller functionality directly with base station transceivers in a compact device, leading to reduced equipment complexity and latency. This design enhances reliability, simplifies installation, lowers costs, and minimizes the system footprint for service providers.

Sonics

Series C in 2004
Sonics is a leading provider of network-on-chip (NoC) technology, specializing in intelligent on-chip communications solutions for various applications, including home entertainment, wireless networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company offers a comprehensive portfolio of silicon-proven intellectual property (IP) that addresses the memory bottlenecks and data flow challenges associated with complex, high-speed system-on-chip (SoC) designs. By enabling heterogeneous, multi-core SoC architectures, Sonics integrates essential subsystems, such as security, power, and memory, to deliver high performance and low power consumption. Its innovative technology has facilitated the shipment of over 750 million units globally, positioning Sonics as a key player in the embedded market.

Atrenta

Series C in 2004
Atrenta is a provider of innovative solutions for the semiconductor and consumer electronics industries, specializing in design efficiency through its SpyGlass Predictive Analysis software platform. This platform offers early design insights into the performance, power, and area requirements of complex system on chips (SoCs), which are essential for modern consumer electronics. By enabling design engineers to identify structural, coding, and consistency issues in register transfer language (RTL), Atrenta's technology allows for enhanced testability during RTL creation. The company's patented solutions are utilized by over two hundred companies and thousands of design engineers globally, helping to mitigate risks and reduce costs before the deployment of traditional electronic design automation (EDA) tools. SpyGlass serves as an interactive guidance system, optimizing the implementation process for complex SoCs and ensuring greater efficiency and confidence in design outcomes.

Ikanos

Series E in 2004
Ikanos Communications, Inc. designs and develops semiconductor and integrated firmware products for the connected home on a global scale. The company specializes in digital subscriber line (DSL) processors and a variety of semiconductor solutions tailored for carrier infrastructure and customer premises equipment. Its offerings include gateway processors that facilitate high-speed access and value-added services for connected homes, as well as multi-mode communications processors for residential gateways. These products support diverse network topologies such as DSL, Ethernet, and LTE, serving telecommunications carriers and cable operators. Ikanos markets its products through direct sales and through partnerships with network equipment manufacturers, original design manufacturers, and distributors. Established in 1999 and based in Fremont, California, Ikanos Communications operates as a subsidiary of Qualcomm Atheros, Inc.

Intellon Corporation

Venture Round in 2004
Intellon Corporation, a fabless semiconductor company, engages in the design, develop, manufacture, and marketing of integrated circuits (ICs) for powerline communications or high-speed communications over existing electrical wiring in the United States and internationally. They provides HomePlug-based ICs for home networking, networked entertainment, broadband over powerline access, ethernet-over-coax, smart grid management, and other commercial applications. The HomePlug-based ICs provide connectivity between broadband modems or routers and personal computers, set-top boxes, gaming consoles, and other electronic products within a home; and monitors electrical distribution system, as well as helps in distributing Internet, video-on-demand, and other services.

CombinatoRx

Series C in 2004
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.

CorrectNet

Series B in 2004
CorrectNet is a leading provider of managed service-based information delivery and client reporting solutions tailored for the investment management sector. Established in 1997, the company specializes in the aggregation, enrichment, quality assurance, and formatting of complex investment data. It serves some of the largest investment management firms globally, offering tools such as the InfiPOINT platform for client reporting and Advisor WebTools for wealth advisors. CorrectNet is recognized for its capability to meet the stringent transparency and reporting requirements of hedge funds, funds of funds, fund administrators, and prime brokers, delivering comprehensive reporting through sophisticated web portals designed for investors, portfolio managers, operations teams, and executives.

Zalicus

Series D in 2004
Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on developing drug candidates for the treatment of pain and inflammation. The company leverages its expertise in ion-channel modulation to discover innovative therapeutics, both for its internal product pipelines and in collaboration with other entities. Zalicus invests significantly in research and development, including preclinical and clinical trials, while also pursuing intellectual property protection for its technologies and product candidates. One of its notable achievements includes the FDA approval of Exalgo, an extended-release formulation of hydromorphone HCl, which is indicated for managing moderate to severe pain in opioid-tolerant patients. The company was formed following the merger with Neuromed Pharmaceuticals in December 2009.

blaze

Series A in 2004
Blaze is the safest, easiest, and most fun way to play online games.

Netrake

Series D in 2004
Netrake Corporation, founded in 2000 and based in Plano, Texas, specializes in providing voice and multimedia solutions for various network operators, including wireline, wireless, and cable providers. The company develops session border controllers that facilitate secure connectivity and policy management for Voice over IP (VoIP) and video sessions across Internet protocol networks. Additionally, Netrake offers security gateways designed to ensure secure real-time communication over Wi-Fi, broadband, and wireless networks, particularly in fixed mobile convergence settings. Its products cater to a range of applications, including carrier-to-carrier peering, residential and Internet service providers, as well as business VoIP access services. As of 2006, Netrake operates as a subsidiary of AudioCodes, Inc.

VeriWave

Series A in 2003
VeriWave specializes in providing testing systems for WiFi and Ethernet networks, focusing on ensuring optimal performance for mobile networks, devices, and applications. The company supports manufacturers, service providers, and end-users throughout the entire lifecycle of mobile technology, from development to deployment and beyond. VeriWave's offerings include tools designed to measure, analyze, and enhance key aspects of mobile performance, such as speed, quality, interoperability, and compliance. Additionally, the company supplies WiFi access points, wireless LAN controllers, residential routers, gateways, WiFi-enabled client devices, Ethernet switches, and branch office routers, catering to the needs of equipment manufacturers and enhancing the overall efficiency of mobile networks.

AirWalk Communications

Venture Round in 2003
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company offers a range of products, including the EdgePoint Femtocell, designed for home and small office use, and the EdgePoint PRO, which caters to office and campus environments. Their PilotStation facilitates the transmission of essential channels in CDMA networks, while the Base Station Manager serves as an open standards-based, scalable solution for managing their software systems. AirWalk's innovative approach integrates controller functionality directly with base station transceivers in a compact device, leading to reduced equipment complexity and latency. This design enhances reliability, simplifies installation, lowers costs, and minimizes the system footprint for service providers.

QuatRx Pharmaceuticals

Series C in 2003
QuatRx Pharmaceuticals is a biopharmaceutical company focused on the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Founded in 2000 and headquartered in Ann Arbor, Michigan, the company offers products such as Osphena, which addresses vaginal atrophy associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related conditions in men. Through its innovative approach, the company aims to improve patient outcomes in these therapeutic areas.

AirWalk Communications

Series A in 2003
AirWalk Communications specializes in providing IP-based Radio Access Network (IP-RAN) solutions tailored for CDMA wireless service providers. The company offers a range of products, including the EdgePoint Femtocell, designed for home and small office use, and the EdgePoint PRO, which caters to office and campus environments. Their PilotStation facilitates the transmission of essential channels in CDMA networks, while the Base Station Manager serves as an open standards-based, scalable solution for managing their software systems. AirWalk's innovative approach integrates controller functionality directly with base station transceivers in a compact device, leading to reduced equipment complexity and latency. This design enhances reliability, simplifies installation, lowers costs, and minimizes the system footprint for service providers.

Atrenta

Series B in 2003
Atrenta is a provider of innovative solutions for the semiconductor and consumer electronics industries, specializing in design efficiency through its SpyGlass Predictive Analysis software platform. This platform offers early design insights into the performance, power, and area requirements of complex system on chips (SoCs), which are essential for modern consumer electronics. By enabling design engineers to identify structural, coding, and consistency issues in register transfer language (RTL), Atrenta's technology allows for enhanced testability during RTL creation. The company's patented solutions are utilized by over two hundred companies and thousands of design engineers globally, helping to mitigate risks and reduce costs before the deployment of traditional electronic design automation (EDA) tools. SpyGlass serves as an interactive guidance system, optimizing the implementation process for complex SoCs and ensuring greater efficiency and confidence in design outcomes.

Immunicon

Series F in 2003
Immunicon develops and commercializes proprietary cell-based diagnostic and research products, primarily focusing on cancer. The company aims to enhance clinical outcomes by providing physicians with improved information for the understanding, diagnosis, treatment, and monitoring of cancer. Its technologies, branded as CellTracks, are designed to identify, count, and characterize small numbers of tumor cells present in blood samples, offering clinically meaningful insights earlier than traditional diagnostic methods. Collaborating with Veridex, LLC, a Johnson & Johnson company, Immunicon contributed to the development of the CellSearch Epithelial Cell Kit, which was submitted for FDA approval for managing metastatic breast cancer. Immunicon anticipates that this kit will be the first product launched based on its technologies. The company also sees potential applications for its technologies in cancer diagnostics, drug development, and research, as well as in other medical fields such as cardiovascular and infectious diseases.

Ikanos

Series D in 2003
Ikanos Communications, Inc. designs and develops semiconductor and integrated firmware products for the connected home on a global scale. The company specializes in digital subscriber line (DSL) processors and a variety of semiconductor solutions tailored for carrier infrastructure and customer premises equipment. Its offerings include gateway processors that facilitate high-speed access and value-added services for connected homes, as well as multi-mode communications processors for residential gateways. These products support diverse network topologies such as DSL, Ethernet, and LTE, serving telecommunications carriers and cable operators. Ikanos markets its products through direct sales and through partnerships with network equipment manufacturers, original design manufacturers, and distributors. Established in 1999 and based in Fremont, California, Ikanos Communications operates as a subsidiary of Qualcomm Atheros, Inc.

eRealty.com

Series E in 2003
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

QuatRx Pharmaceuticals

Series C in 2003
QuatRx Pharmaceuticals is a biopharmaceutical company focused on the discovery, licensing, development, and commercialization of therapeutic compounds targeting endocrine, metabolic, and cardiovascular conditions. Founded in 2000 and headquartered in Ann Arbor, Michigan, the company offers products such as Osphena, which addresses vaginal atrophy associated with estrogen deficiency in post-menopausal women. Additionally, QuatRx develops treatments for testosterone deficiency and other related conditions in men. Through its innovative approach, the company aims to improve patient outcomes in these therapeutic areas.

BayPackets

Series C in 2003
BayPackets' software enables wireless, wireline and cable operators to rapidly bundle and deliver enhanced voice and data services tailored to the needs of their business and consumer customers. Local, long-distance and broadband service providers rely on BayPackets' solutions to profitably expand their market share by efficiently operating new and existing network infrastructure via a single point.

Sopherion Therapeutics

Series A in 2003
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company based in Princeton, New Jersey, with additional offices in Cheshire, Connecticut, and Estero, Florida, as well as a subsidiary in Toronto, Canada. The company specializes in the development and commercialization of oncology therapies, notably Myocet™, a liposome-encapsulated doxorubicin-citrate complex designed to reduce cardiotoxicity. Sopherion holds an exclusive licensing agreement with Cephalon, Inc. for Myocet™ in the United States and Canada. The firm is currently conducting a Phase III global trial to evaluate Myocet™ in combination with Herceptin® and Taxol for treating invasive, metastatic breast cancer. This trial, which aims to recruit 363 patients across twelve countries, builds on promising Phase II results that demonstrated a 96% response rate and a median progression-free survival of two and a half years. Myocet™ is already registered for use in Canada and Europe in combination with cyclophosphamide for similar indications. Sopherion is also exploring additional oncology agents through its Minicell Peptide Display screening technologies.

Ventaira Pharmaceuticals

Series B in 2003
Ventaira Pharmaceuticals is an emerging specialty pharmaceutical company dedicated to the development of innovative inhalation products. The company employs its proprietary electrohydrodynamic aerosolization and formulation technologies to create new inhaled drugs. Among its key products are fentanyl, aimed at treating breakthrough pain, and salmeterol, used for asthma management. Ventaira Pharmaceuticals focuses on advancing its unique technologies to enhance drug delivery and improve treatment options for patients.

VIEO

Series B in 2003
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

eRealty.com

Series D in 2002
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

Netrake

Series C in 2002
Netrake Corporation, founded in 2000 and based in Plano, Texas, specializes in providing voice and multimedia solutions for various network operators, including wireline, wireless, and cable providers. The company develops session border controllers that facilitate secure connectivity and policy management for Voice over IP (VoIP) and video sessions across Internet protocol networks. Additionally, Netrake offers security gateways designed to ensure secure real-time communication over Wi-Fi, broadband, and wireless networks, particularly in fixed mobile convergence settings. Its products cater to a range of applications, including carrier-to-carrier peering, residential and Internet service providers, as well as business VoIP access services. As of 2006, Netrake operates as a subsidiary of AudioCodes, Inc.

Zalicus

Series C in 2002
Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on developing drug candidates for the treatment of pain and inflammation. The company leverages its expertise in ion-channel modulation to discover innovative therapeutics, both for its internal product pipelines and in collaboration with other entities. Zalicus invests significantly in research and development, including preclinical and clinical trials, while also pursuing intellectual property protection for its technologies and product candidates. One of its notable achievements includes the FDA approval of Exalgo, an extended-release formulation of hydromorphone HCl, which is indicated for managing moderate to severe pain in opioid-tolerant patients. The company was formed following the merger with Neuromed Pharmaceuticals in December 2009.

Participate Systems

Series D in 2002
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

Sonics

Series C in 2002
Sonics is a leading provider of network-on-chip (NoC) technology, specializing in intelligent on-chip communications solutions for various applications, including home entertainment, wireless networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company offers a comprehensive portfolio of silicon-proven intellectual property (IP) that addresses the memory bottlenecks and data flow challenges associated with complex, high-speed system-on-chip (SoC) designs. By enabling heterogeneous, multi-core SoC architectures, Sonics integrates essential subsystems, such as security, power, and memory, to deliver high performance and low power consumption. Its innovative technology has facilitated the shipment of over 750 million units globally, positioning Sonics as a key player in the embedded market.

BroadCloud Communications

Series B in 2002
BroadCloud Communications is a web-based application service provider (ASP) of wireless Internet transmission services.

Celarix

Private Equity Round in 2002
Celarix offers simply the best way to manage every aspect of your logistics operation. No longer do you have to piece together disparate information and fill in the gaps yourself. Whether you're a shipper or a transportation service provider, you owe it to yourself and your company to find out exactly what we have in store for you.

Sabeus Photonics

Series C in 2001
Sabeus Photonics optical devices and expand manufacturing facilities. Sabeus supplies optical communications components.

Coriolis Networks

Series C in 2001
Coriolis Networks, headquartered in Boxborough, Mass., began in mid 1999 with a mission to develop a comprehensive approach to the needs of carriers for reliable and scalable optical network solutions. From the beginning, Coriolis Networks realized that success in this market would be based on providing customers with a solution that was compatible with existing SONET network architectures but dramatically improved on the data service delivery capability with new lower price points. Coriolis' target market is the network service provider community on a global basis. Our target customers include competitive and incumbent local exchange carriers, Internet service providers, and wholesale carriers that are building out their fiber-optic facilities to meet their end-user demands for more high-speed data services as well as traditional metro services.

Circadiant Systems

Series B in 2001
Circadiant Systems, Inc. specializes in manufacturing optical test systems designed to meet the needs of optical component developers, network equipment manufacturers, and telecom service providers. The company's product lineup includes an electrical/optical compliance system for testing modules, host cards, and integrated circuits. Key offerings include the HYDRA LRM-M and HYDRA MTS, which address calibration and system correlation issues that can hinder product release and design cycles. Additionally, the optical standard tester-ST generates various optical impairments, automating the performance and conformance testing of 10 Gb/s devices and systems. Circadiant also provides the OSS-RW for creating optical impairments, the OST-SRS for stressed receiver sensitivity conformance testing, and the A3318 for stressed eye measurements. Furthermore, the company offers long reach multimode solutions, protocol layer testing, electronic dispersion compensation testing, and comprehensive system-level testing solutions.

eRealty.com

Series B in 2001
eRealty.com is an online residential real estate brokerage firm that assists buyers and sellers of homes. The company was founded in 1998 and is based in Houston, Texas.

Matrix

Series A in 2001
Provides services to measure Internet performance.

B-there.com

Venture Round in 2001
B-there.com provides online event management solutions for the meeting, trade show, and convention industries. It is based in Westport, Connecticut.

Planalytics (B2B)

Venture Round in 2001
Planalytics, Inc. specializes in business weather intelligence, offering companies insights to understand and manage the impact of weather on their operations. Founded in 1996 and based in Berwyn, Pennsylvania, Planalytics provides analytics, online tools, reports, and consulting services that help organizations quantify weather's influence on demand and operational performance. The company utilizes advanced statistical methods, artificial intelligence, and machine learning to deliver actionable insights, enabling clients to integrate weather considerations into their business practices effectively. With a global presence that includes Europe, Mexico, and Latin America, Planalytics has evolved from a data provider to a comprehensive software-as-a-service platform, enhancing its capabilities to serve a diverse range of industries.

Matrix.Net

Series A in 2001
Incorporated in 1990, MIDS is a pioneer of electronic commerce. MIDS started Matrix IQ the first for-pay non-academic periodical distributed over the Internet drew the first maps of the Internet as a whole, conducted the first demographic survey of the Internet, MIDS Internet Average and first monitored the Internet as a whole. MIDS is known as the granddaddy of Internet monitoring service providers. Since 1993 MIDS has been collecting a continuous stream of data in Their Internet Weather Report MIDS Internet Weather Report. Since 1995, MIDS has been displaying IWR data on the web as animated GIF and Java maps of current conditions in the Internet. MIDS makes geographical maps of Internet hosts, hosts per capita, latencies, links, and other aspects of the Internet available.

VIEO

Series A in 2001
VIEO provides innovative application service level management solutions for ensuring business certainty. These solutions provide end-to-end visibility of Microsoft web-based and Citrix-based application infrastructures and pinpoint resource problems that impact service levels. Using VIEO solutions, IT organizations can improve service delivery while reducing costs and complexity. VIEO's awards include Computerworld's 2004 Innovative Technology Award and InfoWorld's 2004 Systems Management Product of the Year. Led by IT visionary and successful serial entrepreneur Bob Fabbio, VIEO is headquartered in Austin, Texas.

IPnetwork

Series B in 2000
IPnetwork specializes in foreign advertising solutions through various media channels, including television, radio, and internet platforms. Additionally, the company offers an online platform that enables licensing and event sponsorship opportunities. This platform combines software management with information and transaction capabilities, facilitating a range of licensing options for licensors and event sponsors. Through its diverse services, IPnetwork aims to enhance advertising effectiveness and streamline the licensing process for its clients.

Ascentive

Venture Round in 2000
Ascentive is a software development company that specializes in creating user-friendly applications to address everyday PC issues for both consumers and businesses. The company offers a range of products aimed at optimizing, cleaning, and accelerating personal computers, thereby enhancing their performance. With a diverse team of software developers, designers, marketers, and customer service professionals, Ascentive is committed to delivering innovative solutions backed by excellent customer support. The company has established itself as a market leader in the software industry, receiving recognition from various media outlets including The Wall Street Journal and Forbes. Its products are utilized by hundreds of thousands of customers across 55 countries, reflecting its global reach and impact.

Isochron Data

Series A in 2000
Isochron Data Corporation (Isochron) is the leading application service provider of enterprise information solutions and wireless devices for customers seeking to communicate with their distributed field assets. Isochron's solutions connect people, devices, and enterprise systems to provide customers with vital information to improve their top and bottom lines. With Isochron's solutions, managers have direct control over their field assets and immediate access to timely, accurate, and actionable information to better manage their businesses.

Factory Logic

Series A in 2000
Factory Logic, Inc. specializes in factory management solutions, offering the Streamline Lean Factory Management System, an operational management software designed to help factory personnel optimize lean manufacturing processes. This software suite facilitates an integrated approach that aligns production with customer demand while ensuring stability in factory and supply chain operations. Factory Logic also engages in consulting projects, catering to various sectors including automotive, electronics, industrial equipment, and aerospace industries. Founded in 1993 and based in Austin, Texas, the company was previously known as Scintellect Systems, Inc., and has operated as a subsidiary of SAP AG since 2006.

Ineto

Series B in 2000
Ineto operates as a new customer communications service provider.

Highway To Health

Venture Round in 2000
Highway to Health, (HTH) applies its dynamic Internet expertise to bring innovative online healthcare services and insurance to international travel, study, and commerce. Each year thousands of leisure and business travelers as well as international students and scholars protect themselves, their families, and their travel plans with HTH. Their programs combine comprehensive, competitively priced insurance products with critical travel health information, known as CityHealthProfiles, and online medical assistance services available through HTH TravelersClub. Members enjoy access to their community of pre-selected, contracted physicians in over 100 countries, and their interactive translation guides for brand-name pharmaceuticals and common medical terms and phrases.

Powered

Series B in 2000
Powered is a social marketing consultancy that assists companies in enhancing their engagement in a digital and interconnected environment. The firm offers a comprehensive range of services, including strategy development, program execution, content marketing, and blogger outreach. Powered also focuses on influencer activation, advocacy programs, and the creation of branded communities and events. By leveraging effective practices and technologies, Powered aims to help brands and publishers establish and strengthen relationships with their customers through online communities.

WebVision

Series C in 2000
Webvisions provided shared hosting, dedicated server and co-location services to small and midsized businesses throughout Asia.

Go-Active

Venture Round in 2000
Go-Active is a new online application service provider for the health club industry

Utility Associates

Series B in 2000
Utility Associates, Inc. specializes in providing advanced software and hardware solutions primarily for law enforcement, transportation agencies, and utilities. Founded in 2000 and headquartered in Decatur, Georgia, the company offers a range of products designed to enhance mobile field operations and situational awareness. Key offerings include Rocket IOT, which automates evidence gathering, and AVaiL Web, a command and control application that monitors the status and location of personnel and vehicles in real time. Additionally, their BodyWorn camera features voice activation and real-time connectivity, while the Smart Holster detects firearm removal to ensure immediate camera activation. Utility Associates also provides mobile resource management tools, including navigation systems, vehicle diagnostics, and a work management system tailored for the utility sector. Their solutions encompass multimedia storage and connectivity services, aiming to improve operational efficiency and safety for frontline professionals.

BroadCloud Communications

Series A in 2000
BroadCloud Communications is a web-based application service provider (ASP) of wireless Internet transmission services.

ibooks.com

Series B in 2000
ibooks.com is a mobile-based application that enables its users to download and read books on their iPhone, iPod touch, or iPad.

B-there.com

Venture Round in 2000
B-there.com provides online event management solutions for the meeting, trade show, and convention industries. It is based in Westport, Connecticut.

Participate Systems

Series B in 2000
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.